Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 11, 1999, Pages 1147-1155

  Newell, Kathy L ^a   Hyman, Bradley T ^a   Growdon, John H ^a   Hedley Whyte, E Tessa ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer disease; Diagnostic criteria; Neuritic plaques; Neurofibrillary tangles; Topographic staging methods

Indexed keywords

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0032749171     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199911000-00004     Document Type: Article

References (23)

1. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105
2. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
3. The National Institute on Aging, and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Consensus recommendations for the post-mortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18(S4):S1-S2.
4. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
5. Hirano A, Zimmerman HM. Alzheimer's neurofibrillary changes, a topographic study. Arch Neurol 1962;7:227-42
6. Brun A, Gustafson L. Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study. Arch Psychiatr Nervenkr 1976;223:15-33
7. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1991;1:103-16
8. Arriagada PV, Marzloff K, and Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992;42: 1681-88
9. Gertz HJ, Xuereb J, Huppert F, et al. Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease. Acta Neuropathol 1998;95:154-58
10. Hauw J-J, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-19
11. Litvan I, Hauw JJ, Bartko, JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105
12. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-24
13. Vonsattel JPG, Aizawa H, Ge P, et al. An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 1995;54:42-56
14. Gertz H-J, Xuereb JH, Huppert FA, et al. The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample. Eur Arch Psychiatry Clin Neurosci 1996;246:132-36
15. Geddes JW, Snowdon DA, Soultanian NS, et al. Braak stages III-IV of Alzheimer-related neuropathology are associated with mild memory loss, stages V-VI are associated with dementia: Findings from the Nun study [abstract]. J Neuropathol Exp Neurol 1996; 55:617
16. Mann DMA, Jones D. Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome. Neuroscience Letters 1990;109:68-75
17. Sasaki S, Maruyama S, Toyoda C. A case of progressive supranuclear palsy with widespread senile plaques. J Neurol 1991;238: 345-48
18. Gearing M, Olson DA, Watts RL, Mirra SS. Progressive supranu-clear palsy: Neuropathologic and clinical heterogeneity. Neurology 1994;44:1015-24
19. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-39
20. Hansen LA, Masliah E, Galasko D, Terry RD. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993;52:648-54
21. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: A comparative clinicopathological study. Ann Neurol 1994;35:81-88
22. Hansen LA, Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology 1997;48: 126-32
23. Gearing M, Lynn M, Mirra SS. Neurofibrillary pathology in Alzheimer disease with Lewy bodies: Two subgroups. Arch Neurol 1999;56:203-8